학술논문

Dostarlimab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: a placebo-controlled randomized phase 3 trial (ENGOT-EN6-NSGO/GOG-3031/RUBY) (LBA 11)
Document Type
Abstract
Source
In Gynecologic Oncology September 2023 176 Supplement 1:S43-S44
Subject
Language
ISSN
0090-8258